Silverback Therapeutics (SBTX) Competitors

Vera Therapeutics (NASDAQ:VERA) and Silverback Therapeutics (NASDAQ:SBTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability.

Does the MarketBeat Community believe in VERA or SBTX?

Vera Therapeutics received 23 more outperform votes than Silverback Therapeutics when rated by MarketBeat users. Likewise, 66.13% of users gave Vera Therapeutics an outperform vote while only 56.25% of users gave Silverback Therapeutics an outperform vote.

Company	Underperform	Outperform
Vera Therapeutics	Outperform Votes 41 66.13%	Underperform Votes 21 33.87%
Silverback Therapeutics	Outperform Votes 18 56.25%	Underperform Votes 14 43.75%

Do analysts rate VERA or SBTX?

Vera Therapeutics currently has a consensus price target of $64.67, suggesting a potential upside of 169.22%. Given Vera Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Vera Therapeutics is more favorable than Silverback Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vera Therapeutics	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	3 Strong Buy rating(s)	3.20
Silverback Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is VERA or SBTX more profitable?

Silverback Therapeutics' return on equity of -29.62% beat Vera Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vera Therapeutics	N/A	-50.13%	-39.50%
Silverback Therapeutics	N/A	-29.62%	-28.20%

Do institutionals and insiders hold more shares of VERA or SBTX?

99.2% of Vera Therapeutics shares are owned by institutional investors. Comparatively, 74.9% of Silverback Therapeutics shares are owned by institutional investors. 21.7% of Vera Therapeutics shares are owned by company insiders. Comparatively, 34.4% of Silverback Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has better valuation & earnings, VERA or SBTX?

Vera Therapeutics is trading at a lower price-to-earnings ratio than Silverback Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vera Therapeutics	N/A	N/A	-$95.99M	-$2.75	-8.73
Silverback Therapeutics	N/A	N/A	-$89.48M	-$2.42	-5.16

Which has more volatility and risk, VERA or SBTX?

Vera Therapeutics has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Silverback Therapeutics has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500.

Does the media favor VERA or SBTX?

In the previous week, Vera Therapeutics had 5 more articles in the media than Silverback Therapeutics. MarketBeat recorded 6 mentions for Vera Therapeutics and 1 mentions for Silverback Therapeutics. Vera Therapeutics' average media sentiment score of 1.19 beat Silverback Therapeutics' score of 0.00 indicating that Vera Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vera Therapeutics	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Silverback Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Vera Therapeutics beats Silverback Therapeutics on 10 of the 16 factors compared between the two stocks.